Qingxiang Liu

1.7k total citations
26 papers, 1.2k citations indexed

About

Qingxiang Liu is a scholar working on Immunology, Molecular Biology and Surgery. According to data from OpenAlex, Qingxiang Liu has authored 26 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 9 papers in Molecular Biology and 4 papers in Surgery. Recurrent topics in Qingxiang Liu's work include interferon and immune responses (6 papers), Mosquito-borne diseases and control (3 papers) and Immune Cell Function and Interaction (3 papers). Qingxiang Liu is often cited by papers focused on interferon and immune responses (6 papers), Mosquito-borne diseases and control (3 papers) and Immune Cell Function and Interaction (3 papers). Qingxiang Liu collaborates with scholars based in China and United States. Qingxiang Liu's co-authors include Jun Cui, Yaoxing Wu, Weihong Xie, Yanyan Zheng, Rong‐Fu Wang, Shouheng Jin, Yi‐Ping Li, Ling Ma, Jie Zhou and Zefang Wang and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Qingxiang Liu

25 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qingxiang Liu China 15 517 477 297 274 228 26 1.2k
Aaron Wilson United States 20 774 1.5× 180 0.4× 90 0.3× 254 0.9× 277 1.2× 44 1.8k
Jim Boonyaratanakornkit United States 19 303 0.6× 305 0.6× 314 1.1× 49 0.2× 318 1.4× 44 1.3k
Xin Tan China 22 613 1.2× 297 0.6× 166 0.6× 46 0.2× 262 1.1× 63 1.5k
Zhenggang Yang China 15 456 0.9× 191 0.4× 63 0.2× 39 0.1× 367 1.6× 34 934
Steven Nguyen United States 15 521 1.0× 618 1.3× 67 0.2× 69 0.3× 154 0.7× 42 1.3k
Xiaohui Zhou China 20 980 1.9× 571 1.2× 264 0.9× 183 0.7× 487 2.1× 54 1.9k
Larisa Dubrovsky United States 23 830 1.6× 530 1.1× 528 1.8× 66 0.2× 207 0.9× 43 1.8k
Yutaka Amako United States 11 251 0.5× 88 0.2× 75 0.3× 45 0.2× 338 1.5× 13 781
Simon Preston Australia 19 737 1.4× 1.3k 2.8× 186 0.6× 127 0.5× 350 1.5× 31 2.1k
Patrick Schreiner United States 10 610 1.2× 466 1.0× 435 1.5× 44 0.2× 150 0.7× 17 1.3k

Countries citing papers authored by Qingxiang Liu

Since Specialization
Citations

This map shows the geographic impact of Qingxiang Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qingxiang Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qingxiang Liu more than expected).

Fields of papers citing papers by Qingxiang Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qingxiang Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qingxiang Liu. The network helps show where Qingxiang Liu may publish in the future.

Co-authorship network of co-authors of Qingxiang Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Qingxiang Liu. A scholar is included among the top collaborators of Qingxiang Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qingxiang Liu. Qingxiang Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blair, Wade, Yueh–Ming Loo, Marcus J. Bolton, et al.. (2025). FRI-288 Synthetic interferon exhibits potent antiviral activity against HBV with the potential for an improved safety profile. Journal of Hepatology. 82. S773–S773. 1 indexed citations
2.
Liu, Qingxiang, Yanyan Zheng, Ines Sturmlechner, et al.. (2024). IKZF1 and UBR4 gene variants drive autoimmunity and Th2 polarization in IgG4-related disease. Journal of Clinical Investigation. 134(16). 8 indexed citations
3.
Zhang, Yuanpeng, et al.. (2024). A comprehensive study of pulsed high-current secondary electron emission cathode. Journal of Applied Physics. 136(4). 1 indexed citations
4.
Zheng, Yanyan, Qingxiang Liu, Jörg J. Goronzy, & Cornelia M. Weyand. (2023). Immune aging – A mechanism in autoimmune disease. Seminars in Immunology. 69. 101814–101814. 41 indexed citations
5.
Cheng, Xiaoyun, Zhichao Feng, Boyu Pan, et al.. (2023). Establishment and application of the BRP prognosis model for idiopathic pulmonary fibrosis. Journal of Translational Medicine. 21(1). 805–805. 2 indexed citations
6.
Zheng, Yanyan, Liqiu Wang, Qingxiang Liu, et al.. (2023). Modulation of virus-induced neuroinflammation by the autophagy receptor SHISA9 in mice. Nature Microbiology. 8(5). 958–972. 12 indexed citations
7.
Ren, Junming, Qingxiang Liu, Caleb R. Glassman, et al.. (2022). Facile discovery of surrogate cytokine agonists. Cell. 185(8). 1414–1430.e19. 51 indexed citations
8.
Liu, Qingxiang, Yanyan Zheng, Jörg J. Goronzy, & Cornelia M. Weyand. (2022). T cell aging as a risk factor for autoimmunity. Journal of Autoimmunity. 137. 102947–102947. 27 indexed citations
9.
Zhao, Haijian, et al.. (2021). The potential for isotope dilution-LC-MS/MS to improve laboratory measurement of C-peptide: Reasons and critical determinants. SHILAP Revista de lepidopterología. 21. 1–9. 2 indexed citations
10.
Zhou, Weiyan, Qingxiang Liu, Jiangtao Zhang, et al.. (2020). Analysis on the performance of aldosterone testing and the results of EQA in China. Zhonghua jianyan yixue zazhi. 43(3). 267–273. 1 indexed citations
11.
Liu, Qingxiang, et al.. (2019). [Advances in the regulation mechanism of cholinergic anti-inflammatory pathway on sepsis].. PubMed. 31(6). 781–784. 1 indexed citations
12.
Zheng, Yanyan, Qingxiang Liu, Yaoxing Wu, et al.. (2018). Zika virus elicits inflammation to evade antiviral response by cleaving cGAS via NS 1‐caspase‐1 axis. The EMBO Journal. 37(18). 172 indexed citations
13.
Liu, Qingxiang, Yaoxing Wu, Yunfei Qin, et al.. (2018). Broad and diverse mechanisms used by deubiquitinase family members in regulating the type I interferon signaling pathway during antiviral responses. Science Advances. 4(5). eaar2824–eaar2824. 71 indexed citations
14.
Du, Yang, Tianhao Duan, Qingxiang Liu, et al.. (2017). LRRC25 inhibits type I IFN signaling by targeting ISG15‐associated RIG‐I for autophagic degradation. The EMBO Journal. 37(3). 351–366. 139 indexed citations
15.
Wu, Yaoxing, Qingxiang Liu, Jie Zhou, et al.. (2017). Zika virus evades interferon-mediated antiviral response through the co-operation of multiple nonstructural proteins in vitro. Cell Discovery. 3(1). 17006–17006. 177 indexed citations
16.
Qin, Yunfei, Qingxiang Liu, Shuo Tian, et al.. (2016). TRIM9 short isoform preferentially promotes DNA and RNA virus-induced production of type I interferon by recruiting GSK3β to TBK1. Cell Research. 26(5). 613–628. 72 indexed citations
17.
Wang, Yingcai, Richard Connors, Pingchen Fan, et al.. (2014). Structure-assisted discovery of the first non-retinoid ligands for Retinol-Binding Protein 4. Bioorganic & Medicinal Chemistry Letters. 24(13). 2885–2891. 14 indexed citations
18.
Liu, Qingxiang, Xiansheng Liu, Ni Wang, Shixin Chen, & Yongjian Xu. (2012). [Expression of β-catenin in human pulmonary tissues of smokers with and without chronic obstructive pulmonary disease].. PubMed. 35(11). 828–32. 2 indexed citations
19.
Motani, Alykhan, Zhulun Wang, Marion Conn, et al.. (2009). Identification and Characterization of a Non-retinoid Ligand for Retinol-binding Protein 4 Which Lowers Serum Retinol-binding Protein 4 Levels in Vivo. Journal of Biological Chemistry. 284(12). 7673–7680. 68 indexed citations
20.
Motani, Alykhan, Zhulun Wang, Jennifer Weiszmann, et al.. (2009). INT131: A Selective Modulator of PPARγ. Journal of Molecular Biology. 386(5). 1301–1311. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aaron Wilson Breakdown of academic impact, for papers by Jim Boonyaratanakornkit Breakdown of academic impact, for papers by Xin Tan Breakdown of academic impact, for papers by Zhenggang Yang Breakdown of academic impact, for papers by Steven Nguyen Breakdown of academic impact, for papers by Xiaohui Zhou Breakdown of academic impact, for papers by Larisa Dubrovsky Breakdown of academic impact, for papers by Yutaka Amako Breakdown of academic impact, for papers by Simon Preston Breakdown of academic impact, for papers by Patrick Schreiner
Rankless by CCL
2026